Bios Partners — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Stream Biomedical is a clinical-stage biotechnology company developing LG3, a biologic derived from a natural repair protein intended to protect and restore the brain by activating its repair systems.
BiotechDeep TechHealthtechHouston, US
H. Davis Adkisson(Chief Scientific Officer)inChris Garabedian(Director)William Schwieterman(Board of Directors)Fred Callori(Director)
BoardAmanda De La Garza(Director)in
Co-investorsCowtown Angels
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
